Scandcleft randomized trials of primary surgery for unilateral cleft lip and palate. Dental arch relationships in 8 year-olds.


Journal

European journal of orthodontics
ISSN: 1460-2210
Titre abrégé: Eur J Orthod
Pays: England
ID NLM: 7909010

Informations de publication

Date de publication:
27 Jan 2020
Historique:
pubmed: 4 10 2019
medline: 4 3 2020
entrez: 4 10 2019
Statut: ppublish

Résumé

The Scandcleft intercentre study evaluates the outcomes of four surgical protocols for treatment of children with unilateral cleft lip and palate (UCLP). Originally 10 cleft centres in Denmark, Finland, Norway, Sweden, and the UK participated in a set of three randomized trials of primary surgery. Three groups of centres (Trials 1, 2, and 3) tested their traditional local surgical protocols (Arms B, C, and D) against a common protocol (Arm A). To evaluate dental arch relationships at age 8 years after four different protocols of primary surgery for UCLP. These results are secondary outcomes of the overall trial. Study models of 411 children (270 boys, 141 girls) with non-syndromic UCLP at a mean age of 8.1 (range 7.0-10.0) years were available. Dental arch relationships were analysed using the GOSLON Yardstick by a blinded panel of 11 orthodontists. To assess reliability, Kappa statistics were calculated. The trials were tested statistically with t-tests. Comparisons within each trial showed no statistically significant differences in the mean 8-year index scores or their distributions between the common protocol and the local team protocol. The mean index scores were Trial 1: Arm A 3.03, Arm B 2.82, Trial 2: Arm A 2.78, Arm C 2.64, and Trial 3: Arm A 3.06, Arm D 3.08. Comparisons between the trials detected a significantly (P < 0.005) better mean index score Trial 2 Arm C than in Trial 3 Arm D. The intra- and inter-rater reliabilities were acceptable. The results of these three trials do not provide evidence that one surgical protocol is better than the others. ISRCTN29932826.

Sections du résumé

BACKGROUND AND TRIAL DESIGN UNASSIGNED
The Scandcleft intercentre study evaluates the outcomes of four surgical protocols for treatment of children with unilateral cleft lip and palate (UCLP). Originally 10 cleft centres in Denmark, Finland, Norway, Sweden, and the UK participated in a set of three randomized trials of primary surgery. Three groups of centres (Trials 1, 2, and 3) tested their traditional local surgical protocols (Arms B, C, and D) against a common protocol (Arm A).
OBJECTIVES OBJECTIVE
To evaluate dental arch relationships at age 8 years after four different protocols of primary surgery for UCLP. These results are secondary outcomes of the overall trial.
METHODS METHODS
Study models of 411 children (270 boys, 141 girls) with non-syndromic UCLP at a mean age of 8.1 (range 7.0-10.0) years were available. Dental arch relationships were analysed using the GOSLON Yardstick by a blinded panel of 11 orthodontists. To assess reliability, Kappa statistics were calculated. The trials were tested statistically with t-tests.
RESULTS RESULTS
Comparisons within each trial showed no statistically significant differences in the mean 8-year index scores or their distributions between the common protocol and the local team protocol. The mean index scores were Trial 1: Arm A 3.03, Arm B 2.82, Trial 2: Arm A 2.78, Arm C 2.64, and Trial 3: Arm A 3.06, Arm D 3.08. Comparisons between the trials detected a significantly (P < 0.005) better mean index score Trial 2 Arm C than in Trial 3 Arm D. The intra- and inter-rater reliabilities were acceptable.
CONCLUSION CONCLUSIONS
The results of these three trials do not provide evidence that one surgical protocol is better than the others.
TRIAL REGISTRATION BACKGROUND
ISRCTN29932826.

Identifiants

pubmed: 31579909
pii: 5580440
doi: 10.1093/ejo/cjz067
doi:

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-7

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the European Orthodontic Society. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Arja Heliövaara (A)

Cleft Palate and Craniofacial Center, Department of Plastic Surgery, Helsinki University Hospital, Finland.

Pål Skaare (P)

Department of Plastic and Reconstructive Surgery, Oslo University Hospital Rikshospitalet, Norway.

Annelise Küseler (A)

Cleft Palate Center and University Hospital Aarhus and University of Aarhus, Denmark.

William Shaw (W)

Dental School, University of Manchester, UK.

Kirsten Mølsted (K)

Copenhagen Cleft Palate Center, University Hospital of Copenhagen, Denmark.

Agneta Karsten (A)

Section for Orthodontics, Division of Orthodontics and Pedodontics, Department of Dental Medicine, Karolinska Institutet and Stockholm Craniofacial Team, Sweden.

Agneta Marcusson (A)

Maxillofacial Unit and Department of Clinical and Experimental Medicine, Linköping University, Sweden.

Eli Brinck (E)

Department of Plastic and Reconstructive Surgery, Oslo University Hospital Rikshospitalet, Norway.

Sara Rizell (S)

Specialist Clinic for Orthodontics, University Clinics of Odontology, Public Dental Health Service, Västra Götaland Region, Sweden.

Paul Sæle (P)

Oral Health Center of Expertise/Western Norway, Bergen, Norway.

Midia Najar Chalien (M)

Specialist Clinic for Orthodontics, University Clinics of Odontology, Public Dental Health Service, Västra Götaland Region, Sweden.

Haydn Bellardie (H)

Dental School, University of Manchester, UK.
The University of the Western Cape, South Africa.

Jeanette Mooney (J)

Dental School, University of Manchester, UK.

Phil Eyres (P)

Dental School, University of Manchester, UK.

Gunvor Semb (G)

Department of Plastic and Reconstructive Surgery, Oslo University Hospital Rikshospitalet, Norway.
Dental School, University of Manchester, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH